Related Experiment Videos
Changes in affect during treatment for depression and anxiety
Ann M Kring1, Jacqueline B Persons, Cannon Thomas
1Department of Psychology, 3210 Tolman Hall, University of California Berkeley, Berkeley, CA 94720, USA. akring@berkeley.edu
Behaviour Research and Therapy
|March 22, 2007
Summary
The tripartite model effectively explains changes in anxiety and depression during cognitive behavior therapy. Shared factors like negative affect significantly influence treatment outcomes for both conditions.
Area of Science:
- Psychology
- Clinical Psychology
- Psychopathology
Background:
- The tripartite model posits distinct yet overlapping dimensions of anxiety and depression.
- Understanding these dimensions is crucial for effective treatment of mood and anxiety disorders.
Purpose of the Study:
- To test the applicability of the tripartite model to treatment change in anxiety and depression.
- To investigate the roles of negative affect (NA), positive affect (PA), and anxious arousal (AA) during cognitive behavior therapy.
Main Methods:
- A naturalistic study involving 41 patients receiving cognitive behavior therapy.
- Weekly assessments of depression, anxiety, NA, PA, and AA throughout treatment.
Main Results:
- NA correlated with both anxiety and depression during treatment.
- AA was more strongly linked to anxiety, while PA showed a stronger relation to depression.
- Symptoms of depression, anxiety, NA, and AA decreased during treatment.
- PA increased only in patients with significant depression reduction over time.
- Shared variance between anxiety and depression change was substantial, largely explained by NA and the other disorder.
Conclusions:
- The tripartite model provides a robust framework for understanding treatment-related changes in anxiety and depression.
- Negative affect, positive affect, and anxious arousal play distinct but interconnected roles in treatment.
- Shared variance highlights the common underlying processes influencing recovery from both conditions.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Behavior Therapy
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
01:54The Placebo Effect
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:18Anxiety: Overview
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
01:26Anxiolytic Drugs: Overview
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.